Biblio

Author Title [ Type

] Year

Filters: Author is Park, Hun-Jun [Clear All Filters]

Journal Article

Jang J, Park H-J, Kim S-W, Kim H, Park JYoung, Na SJin, Kim HJi, Park MNyeo, Choi SHyun, Park SHwa, et al. 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair. Biomaterials. 2016;112:264-274.

Choi SWoo, Shin JSoo, Park S-J, Jung E, Park Y-G, Lee J, Kim SJoon, Park H-J, Lee J-H, Park S-M, et al. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral Res. 2020:104955.

Ban K, Park H-J, Kim S, Andukuri A, Cho K-W, Hwang JWook, Cha HJin, Kim SYoon, Kim W-S, Jun H-W, et al. Cell Therapy with Embryonic Stem Cell-Derived Cardiomyocytes Encapsulated in Injectable Nanomatrix Gel Enhances Cell Engraftment and Promotes Cardiac Repair. ACS Nano. 2014.

Park YSoo, Park B-W, Choi H, Lee SHee, Kim M, Park H-J, Kim I-B. Chorion-derived perinatal mesenchymal stem cells improve cardiac function and vascular regeneration: preferential treatment for ischemic heart disease. Hellenic J Cardiol. 2022.

Park S-J, Kim H, Lee S, Kim J, Jung T-H, Choi SWoo, Park B-W, Kang S-W, Elliott DA, Stanley EG, et al. Effect and application of cryopreserved three-dimensional microcardiac spheroids in myocardial infarction therapy. Clin Transl Med. 2022;12(1):e721.

Jeong S-Y, Park B-W, Kim J, Lee S, You H, Lee J, Lee S, Park J-H, Kim J, Sim W, et al. Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct. J Nanobiotechnology. 2024;22(1):149.

Choi A, Kim H, Han H, Park J-H, Kim J-J, Sim W-S, Lee SJin, Ban K, Park H-J, Kim DSung. Sutureless transplantation of in vivo priming human mesenchymal stem cell sheet promotes the therapeutic potential for cardiac repair. Biofabrication. 2022.

Kim J-J, Park J-H, Kim H, Sim W-S, Hong S, Choi Y-J, Kim H-J, Lee SMin, Kim D, Kang S-W, et al. Vascular regeneration and skeletal muscle repair induced by long-term exposure to SDF-1α derived from engineered mesenchymal stem cells after hindlimb ischemia. Exp Mol Med. 2023.